JWCA
ELV icon

J.W. Cole Advisors’s Elevance Health ELV Stock Holding History

J.W. Cole Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$703K Buy
1,818
+377
+26% +$140K 0.01% 876
2026
Q1 		$422K Sell
1,441
-202
-12% -$66.4K 0.01% 542
2025
Q4 		$501K Sell
1,643
-600
-27% -$203K 0.01% 905
2025
Q3 		$725K Sell
2,243
-214
-9% -$66.6K 0.01% 848
2025
Q2 		$956K Buy
2,457
+656
+36% +$264K 0.02% 685
2025
Q1 		$783K Buy
1,801
+418
+30% +$168K 0.02% 616
2024
Q4 		$510K Buy
1,383
+58
+4% +$24.3K 0.02% 595
2024
Q3 		$689K Buy
1,325
+49
+4% +$26.2K 0.03% 489
2024
Q2 		$692K Buy
1,276
+139
+12% +$73.5K 0.03% 431
2024
Q1 		$589K Buy
1,137
+143
+14% +$71.1K 0.03% 488
2023
Q4 		$469K Buy
994
+109
+12% +$50.4K 0.03% 507
2023
Q3 		$385K Sell
885
-108
-11% -$49K 0.03% 488
2023
Q2 		$441K Sell
993
-69
-6% -$31.8K 0.03% 459
2023
Q1 		$488K Buy
1,062
+6
+0.6% +$2.85K 0.03% 454
2022
Q4 		$542K Sell
1,056
-2
-0.2% -$1.01K 0.04% 401
2022
Q3 		$481K Sell
1,058
-4
-0.4% -$1.91K 0.04% 408
2022
Q2 		$512K Hold
1,062
– – 0.04% 404
2022
Q1 		$522K Sell
1,062
-3
-0.3% -$1.37K 0.04% 440
2021
Q4 		$494K Buy
1,065
+4
+0.4% +$1.68K 0.03% 468
2021
Q3 		$396K Sell
1,061
-2
-0.2% -$760 0.03% 297
2021
Q2 		$406K Sell
1,063
-60
-5% -$22.9K 0.03% 493
2021
Q1 		$403K Buy
1,123
+198
+21% +$63.7K 0.04% 434
2020
Q4 		$297K Buy
+925
New +$284K 0.03% 480
2020
Q1 		– Sell
-1,244
Closed -$376K – 206
2019
Q4 		$376K Buy
+1,244
New +$342K 0.05% 364

Other funds holding ELV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

J.W. Cole Advisors's ELV Position: Q2 2026 in Review

J.W. Cole Advisors increased its Elevance Health (ELV) stake by 26% in Q2 2026, buying an estimated $140K and bringing the position to 1,818 shares worth $703K. The position accounts for 0.01% of the portfolio, ranked #876.

J.W. Cole Advisors first reported a position in ELV in Q4 2019 and has held it in 24 quarters since. The position peaked at $956K in Q2 2025. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • J.W. Cole Advisors held 1,818 shares of Elevance Health worth $703K as of Q2 2026.
  • J.W. Cole Advisors bought 377 Elevance Health shares in Q2 2026, an estimated $140K.
  • Elevance Health made up 0.01% of J.W. Cole Advisors's portfolio in Q2 2026, its #876 holding.
  • J.W. Cole Advisors first reported a position in Elevance Health in Q4 2019 and has held it in 24 quarters since.
  • J.W. Cole Advisors's Elevance Health position peaked at $956K in Q2 2025.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.